Which malignancies are associated with obesity as a risk factor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Obesity-Associated Cancers: A Comprehensive Overview

Obesity is a confirmed risk factor for at least 13 types of cancer, with the strongest evidence supporting increased risk for postmenopausal breast, endometrial, colorectal, esophageal adenocarcinoma, kidney, pancreatic, liver, gallbladder, ovarian, thyroid (papillary, follicular, and anaplastic), bladder cancers, and hematologic malignancies including multiple myeloma, acute myeloid leukemia, and both Hodgkin and non-Hodgkin lymphoma. 1

Solid Organ Malignancies with Clear Associations

Gastrointestinal Cancers

  • Colorectal cancer: Consistently elevated risk across multiple studies, with abdominal adiposity particularly implicated 1
  • Esophageal adenocarcinoma: Strong association, likely mediated through gastroesophageal reflux disease and Barrett's esophagus 2
  • Gastric cancer: Increased risk, particularly in women with diabetes 1
  • Pancreatic cancer: Evidence is highly suggestive of increased risk 2
  • Liver cancer: Clear association, with sex differences noted (higher risk in men) 1
  • Gallbladder cancer: Elevated risk with obesity 2

Genitourinary Cancers

  • Kidney (renal cell) cancer: Clearly associated with increased BMI 2
  • Bladder cancer: Increased risk, potentially higher in men 1

Gynecologic Cancers

  • Endometrial cancer: Among the strongest associations, with obesity conferring a 2.54-fold increased risk (95% CI 2.11-3.06) 1
  • Ovarian cancer: Evidence supports increased risk 2
  • Cervical cancer: Suggestive evidence of increased risk 2
  • Postmenopausal breast cancer: Clear association, though premenopausal women may have paradoxically lower overall risk (except for hormone receptor-negative subtypes) 1, 2

Other Solid Tumors

  • Thyroid cancer: Increased risk for papillary, follicular, and anaplastic subtypes, but notably NOT medullary thyroid cancer 1

Hematologic Malignancies

Obesity increases risk for multiple blood cancers 1:

  • Acute myeloid leukemia
  • Multiple myeloma
  • Non-Hodgkin lymphoma
  • Hodgkin lymphoma

Important Nuances and Exceptions

Prostate Cancer Paradox

The relationship with prostate cancer is complex: there's an inverse relationship between BMI and overall prostate cancer incidence 1, but obesity is associated with high-grade aggressive prostate cancers 2. This association may vary by race, with increased risk observed in African American men 1.

Lung Cancer Exception

Increased BMI may be protective for lung cancer in never-smokers 1, though abdominal obesity measured by waist circumference shows increased risk across all smoking categories 1.

Breast Cancer Age Dependency

In premenopausal women, increased BMI may be protective overall for breast cancer but NOT for hormone receptor-negative breast cancer 1.

Risk Modifiers

Cancer risk from obesity is modified by 1:

  • Age
  • Sex
  • Race/ethnicity
  • Menopausal status
  • Duration of obesity
  • Distribution of adiposity (central vs. peripheral)
  • Presence of metabolic syndrome components

Mechanistic Pathways

The pathophysiologic mechanisms driving obesity-related cancer risk include 1:

  • Hyperinsulinemia and insulin resistance
  • Elevated insulin-like growth factors (IGF-1)
  • Adipokine imbalance
  • Chronic inflammatory cytokines
  • Angiogenic factors
  • Increased systemic estrogen from peripheral aromatization
  • Local adipose tissue-tumor microenvironment interactions

Clinical Implications

Clinicians should recommend age-, sex-, and risk-appropriate cancer screening for all patients with obesity, with particular attention to the cancers listed above 1. The 2022 American Association of Clinical Endocrinology guidelines emphasize that up-to-date cancer screening is imperative but often not met in persons with obesity 1.

Education about cancer risk should be provided to encourage adherence to lifestyle modifications and weight loss 1, as obesity contributes to 14-20% of all cancer-related mortality in the United States 2.

References

1
Guideline

american association of clinical endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan-2022 update.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2022

Related Questions

Are there Food and Drug Administration (FDA)‑approved appetite‑suppressing medications for obesity management?
What stimulant is most appropriate for weight loss in a 35-year-old adult with obesity?
What ASA physical status classification should be assigned to a patient with obesity based on BMI and any associated comorbidities?
In an obese patient with a cervical collar undergoing cervical spine surgery, which site is preferred for central venous catheter placement?
Are adult male sumo wrestlers with body weight >150 kg and BMI >35 kg/m² considered unhealthy due to obesity‑related comorbidities?
What is the appropriate treatment for acute bleeding due to diverticulosis?
What do the MRI findings of a focal cervical disc herniation with foraminal and spinal stenosis, minimal lumbar interspinous ligament signal increase, and a low‑positive antinuclear antibody ribonucleoprotein (RNP) level (4.7 U) indicate in a patient whose complete blood count, comprehensive metabolic panel, kidney function, and liver function tests are normal?
What are the possible causes and recommended management for posterior knee pain in the absence of red‑flag symptoms?
What are the recommended first-line treatment options for depressive episodes in bipolar I disorder?
Could my cervical disc herniation with foraminal stenosis, mild lumbar inter‑spinous ligament changes, and low‑positive anti‑RNP antinuclear antibody explain the generalized muscle weakness I've had for two months, which coincides with recurrent sinus infections and a recent upper‑respiratory infection?
In a patient with Proteus mirabilis infection who completed a 7‑day course of amoxicillin‑clavulanate, should we wait another week before obtaining a repeat culture after the culture drawn 5 days post‑therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.